SHSE:600351 (China)  
Yabao Pharmaceutical Group Co Ltd logo

Yabao Pharmaceutical Group Co Ltd

¥ 6.24 (+0.16%) Aug 17
P/E:
25.02
P/B:
1.61
Market Cap:
¥ 4.80B ($ 707.61M)
Enterprise V:
¥ 4.85B ($ 716.11M)
Volume:
6.39M
Avg Vol (2M):
17.77M
Volume:
6.39M
Market Cap ¥:
4.80B
Market Cap $:
707.61M
PE Ratio:
25.02
Avg Vol (2-Month):
17.77M
Enterprise Value ¥:
4.85B
Enterprise Value $:
716.11M
PB Ratio:
1.61
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download Tutorials

Business Description

Yabao Pharmaceutical Group Co Ltd
NAICS : 325412
No.43 Fumin Road, Ruicheng, Shanxi Province, Yuncheng, CHN, 044602
Description
Yabao Pharmaceutical Group Co Ltd is engaged in the manufacture and operation of western and Chinese medicines, APIs, health care products, packing materials for medicine, and also engages in the planting and processing of medicinal herbs.

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil ¥) 2,665.047
EPS (TTM) (¥) 0.249
Beta 1.56
Volatility % 70.9
14-Day RSI 47.53
14-Day ATR (¥) 0.151172
20-Day SMA (¥) 6.23
12-1 Month Momentum % 0.48
52-Week Range (¥) 5.48 - 11.9
Shares Outstanding (Mil) 770

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 7
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Yabao Pharmaceutical Group Co Ltd Filings

Document Form Filing Date
No Filing Data